ONO-4059

DRUG2 trials

Sponsors

Ono Pharmaceutical Co. Ltd, Ono Pharmaceutical Co., Ltd.

Conditions

PemphigusPrimary Central Nervous System LymphomaSteroid-resistant Pemphigus

Phase 1

Phase I Study Evaluating Tolerability, Safety, Pharmacokinetics, and Efficacy of Combined ONO-4059 and R-MPV Therapy for PCNSL

Active, not recruitingNCT06541665

Ono Pharmaceutical Co. LtdPrimary Central Nervous System Lymphoma

Start: 2024-05-17End: 2028-08-31Target: 20Updated: 2025-06-03

Phase 3

ONO-4059 Study in Patients With Steroid-resistant Pemphigus

Active, not recruitingNCT06696716

Ono Pharmaceutical Co., Ltd.Pemphigus, Steroid-resistant Pemphigus

Start: 2022-08-15End: 2029-03-31Target: 34Updated: 2026-07-20